The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults by Ching-Jung Hsieh et al.
METABOLIC SYNDROME
DIABETOLOGY & 
Hsieh et al. Diabetology & Metabolic Syndrome 2014, 6:49
http://www.dmsjournal.com/content/6/1/49RESEARCH Open AccessThe relationship between regional abdominal
fat distribution and both insulin resistance and
subclinical chronic inflammation in non-diabetic
adults
Ching-Jung Hsieh*, Pei-Wen Wang and Tse-Ying ChenAbstract
Objective: Obesity is associated with a high risk of insulin resistance (IR) and its metabolic complications. It is still
debated that distributions of adipose tissue relate to an excess risk of IR and chronic inflammation in different race.
This study was designed to examine the relation between insulin sensitivity, chronic inflammation and central fat
distribution in non-diabetic volunteers in Taiwanese.
Methods: There were 328 volunteers without family history of diabetes mellitus and with normal oral glucose
tolerance test enrolled. Total body fat and abdominal fat were measured. Abdominal fat was categorized into
intraperitoneal (IP), retroperitoneal (RP) and subcutaneous (SC) fat. The IR index was estimated by homeostatic
model assessment. Five inflammatory markers: adiponectin, leptin, tumor necrosing factor-α (TNF-α), resistin and
high sensitive CRP (hs-CRP) were measured.
Results: IR was related to IP fat (r = 0.23, p < 0.001), but not RP fat, SC fat or total body fat. After correcting for age
and sex, IP fat was the only significant predictor of IR (r2 = 58%, p = 0.001). Leptin showed the strongest relationship
with all fat compartments (IP fat: r = 0.44, p = 0.001; RP fat: r = 0.36, p = 0.005, SC fat: r = 0.54, p < 0.001; total body fat:
r = 0.61, p < 0.001). The hs-CRP and adiponectin were closely related both to IP (r = 0.29, p = 0.004; r = −0.20, p = 0.046,
respectively) and total body fat (r = 0.29, p = 0.004; r = −0.29, p = 0.005, respectively), but not RP, or SC fat. TNF-α and
resistin were not correlated to any fat compartment. After correcting for age and sex, leptin variance was mostly
explained by SC fat (41.3%), followed by IP fat (33.6%) and RP fat (25.3%). The hs-CRP and adiponectin variance were
mostly explained by IP fat (40% and 49% respectively).
Conclusions: IP fat is better predictors of IR and subclinical chronic inflammation in Taiwanese adults. A
disproportionate accumulation of abdominal fat is associated with increased risk of cardiovascular diseases.
Keywords: Subcutaneous fat, Intra-peritoneal fat, Retroperitoneal fat, Insulin resistance, High sensitive C-reactive
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The prevalence of obesity and overweight are still in-
creasing globally. Compared to other countries of Asian,
Taiwan has a higher percentage of people who are obese
than Australia, Germany, New Zealand and the UK. In
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reproduction in any medium, provided the orare 19.2% and 30.5% in men, 13.4% and 21.3% in women
[1]. Central obesity, as waist circumference, is clearly
related to high risk of insulin resistance and the associ-
ated metabolic complications. From most studies, a
more abdominal distribution of fat is associated with
type 2 diabetes mellitus and worse outcome of cardiovascu-
lar disease [2]. The abdominal fat includes subcutaneous
(SC) fat of abdomen, intraperidonial (IP) fat and retroperi-
donial (RP) fat. However, most studies revealed the meta-
bolic complication with visceral fat and SC fat of abdomentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ship of metabolic complication with these three reginal fat
distribution and separate viseral fat to IP fat and RP fat,
eapecially in Asian. How adipose tissue causes metabolic
abnormality is often linked with adipokines and other
inflammation markers [5,6]. The most well studied adi-
pokines are leptin and adiponectin. Resistin and TNF-α
secreted by adipose tissue may also play roles on regulate
insulin resistance [7]. However, how the regional distribu-
tion of abdominal adipose tissue affects this adipokines is
still controversial in different race. Most studies verified
visceral area fat (also known as intra-abdominal fat) is
strongly associated with insulin resistance but seldom
analyze the fat distribution in the abdomen. Presence of
brown adipose tissue, a metabolically highly active organ
with increased thermogenic activity, in RP fat is always
neglected. As for subcutaneous fat, the correlation to insu-
lin resistance is still debated [8-11]. These inconsistent re-
sults are likely because of marked differences in ethnicity
of the cohorts studied.
On account of different ethnicity may have different
distribution of abdominal fat, in this study, we investigate
regional fat deposition of abdomen, homeostatic model
assessment for insulin resistance (HOMA-IR) and chronic
inflammation factors in healthy non-diabetic Taiwanese
adults with large population. The relationship between
regional fat deposition and both insulin resistance and
chronic inflammation are analyzed. This study was de-
signed to examine the relation between insulin sensitivity,
chronic inflammation and central fat distribution in
non-diabetic volunteers in Taiwanese.
Materials and methods
Subjects
There were 328 volunteers enrolled to participate in the
study. They all had normal blood glucose (179 women
and 149 men aged 41 to 59 years; mean ± SD, 49.2 ±
9.0 years) defined by fasting blood glucose less than
100 mg/dL and normal oral glucose tolerance test.
Subjects included in this study were all over 40 years
old, ethnically Chinese, and from the same region in
Taiwan at the time of study. The exclusion criteria
were diabetes, hypertension, chronic alcohol drinking
and family history with diabetes mellitus, determined
by taking a history. Four measurements were taken of
all subjects after fasting for more than 8 hours (fasting
blood glucose and insulin levels, total body fat, and ab-
dominal fat measurement). Five inflammatory markers:
adiponectin, leptin, tumor necrosing factor-α (TNF-α),
resistin and high sensitive CRP (hs-CRP) were also
measured. The Medical Ethics and Human Clinical Trial
Committee of Chang Gung Memorial Hospital approved
the study, and all subjects provided written informed
consent before participating.Methods
Total body fat mass was measured by electrical bioimpe-
dance analysis (BIA), tetra-polar vertical BIA using 8-point
tactile electrode (InBody 230, BioSpace Inc., Los Angeles,
CA, USA). All subjects were tested after eight-hour fast
while wearing light clothing and empting urinary bladder.
Abdominal fat was measured by computed tomography
(CT). The average Hounsfield values from five 3-mm-slices
was calculated. Abdominal fat was categorized into three
distinct compartments, the intra-peritoneal, retroperitoneal
and subcutaneous fat compartments. These were measured
at an attenuation range of −150 to −50 Hounsfield units at
the L1-2 vertebral disk level. Distinction between retroperi-
toneal and intra-peritoneal fat areas was defined by drawing
straight lines from the mid-point between the abdominal
aorta and the inferior vena cava through the centers of the
descending and ascending colon (Figure 1).
Assay
The plasma concentrations of glucose (Hitachi 7250 Special
auto-analyzer; Hitachi, Tokyo, Japan) and insulin (Access
automated immunoassay; Beckman Instruments, Fullerton,
CA) were measured. Insulin resistance (IR) was determined
by homeostasis model assessment (HOMA) and calculated
using fasting plasma glucose and fasting insulin levels in
each participant, as follows: HOMA IR = fasting glucose
(mmol/l) × fasting insulin (mU/ml)/22.5.
Inflammatory markers: adiponectin, TNF-α, and resistin
were checked with commercially available ELISA kits
(R&D Systems Inc). The lower limit of fasting adiponectin
detection with this assay was 0.89 ng/ml. The intra-assay
coefficients of variation were 2.5, 3.4, and 4.7% at low
(19.8 ng/ml), median (69.9 ng/ml) and high (143 ng/ml)
levels, respectively. The inter-assay coefficients of vari-
ation were 6.8, 5.8 and 6.9% at low (20.5 ng/ml), median
(74.4 ng/ml) and high (157 ng/ml) levels. The lower
limit of resistin concentration detection with this assay
was 0.055 ng/ml. The intra-assay coefficients of variation
were 5.0, 5.3, and 3.8% at low (0.60 ng/ml), median
(2.26 ng/ml) and high (4.72 ng/ml) levels. Inter-assay
coefficients of variation were 8.2, 9.2 and 7.8% at low
(0.61 ng/ml), median (2.28 ng/ml) and high (4.72 ng/ml)
levels. The lower limit of TNF-αconcentration detection
with this assay was 0.5-5.5 pg/ml. The intra-assay coef-
ficients of variation were 5.2, 4.2, and 4.6% at low
(48.1 pg/ml), median (317 pg/ml) and high (587 pg/ml)
levels. The inter-assay coefficients of variation were 7.4,
4.6 and 5.4% at low (45.8 pg/ml), median (301 pg/ml) and
high (587 pg/ml) levels, respectively.
The serum hs-CRP level was measured using a high-
sensitivity% monoclonal antibody assay (Diagnostic Sys-
tems Laboratories, Inc). The run-to-run CVs, at hs-CRP
concentrations of 19.6, 182.9, and 300.4 ng/ml were 3.6,
3.9, and 2.1%.
Figure 1 The CT of abdomen shows measurement of intra-peritoneal fat (blue line), retro-peritoneal fat (yellow line) and subcutaneous
fat (red line).
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Leptin RIA kit, Linco Research, MO, USA). Intra-assay
coefficients of variation were 8.3, 3.9, and 3.4% at low
(4.9 ng/ml), median (10.4 ng/ml) and high (25.6 ng/ml)
levels. The inter-assay coefficients of variation were 6.2,
4.7 and 3.6% at low (4.9 ng/ml), median (10.4 ng/ml) and
high (25.6 ng/ml) levels. Analytical sensitivity remained at
a level of around 0.5 ng/ml.
All statistical analyses were performed using the
Statistical Package for Social Science program (SPSS for
Windows, version 11.5; SPSS, Chicago, IL). Continuous
variables were expressed as means ± SD. The relationships
in variable pairs were analyzed by Person correlation coef-
ficients and stepwise multiple regression analyses. The
level of significance was taken as P = less than 0.05.
Results
Study group characteristics are given in Table 1.
Relation between fat compartments and insulin resistance
The IP fat compartment was significantly related to
HOMA IR (r = 0.23, p < 0.00, Figure 2A). The RP fat, SC
fat compartment and total body fat showed no relationship
to HOMA IR (r = 0.022, p = 0.729; r = 0.052, p = 0.27,
r = 0.18, p = 0.075, respectively, Figure 2B and 2C). Stepwise
regression analysis showed that the IP fat compartmentwas the only significant predictor of insulin resistance
(r2 = 58%, p = 0.001).
Relations between fat compartment and chronic
inflammation markers after correct for age and sex
In the Table 2, the hs-CRP was closely related to IP fat
(r = 0.29, p = 0.004) and total body fat (r = 0.29, p = 0.004),
but not to the RP fat or SC fat (r = 0.20, p = 0.084; r = 0.13,
p = 0.216, respectively).
Leptin showed the strongest relationship with all fat
compartments (IP fat: r = 0.44, p = 0.001; RP fat: r = 0.36,
p = 0.005, SC fat: r = 0.54, p < 0.001; total body fat: r = 0.61,
p < 0.001, Table 2). In a stepwise regression analysis, SC
fat explained 41.3% of the variance of leptin levels, IP fat
explained 33.6%, and the RP fat explained 25.3%.
Adiponectin was closely related to IP fat (r = −0.20, p =
0.046) and total body fat (r = −0.29, p = 0.005), but not to
the SC and RP fat (r = 0.19, p = 0.335; r = −0.13, p = 0.222,
respectively, Table 2). In a stepwise regression analysis, the
IP fat explained 49% of the variance of adiponectin levels.
TNF-α and resistin were not correlated to all fat
compartment.
Discussion
In this study, we found the relationship between regional
abdominal adiposity and insulin resistance in a group of
Table 1 The characteristics of the study group
Minimum Maximum Mean Standard
deviation
Age (year-old) 41 59 49.20 9.00
BMI 17.51 39.26 28.58 10.27
Body fat (%) 13.00 41.20 27.66 14.75
Intra-peritoneal fat (cm3) 7550.00 56835.40 29188.67 21382.91
Retro-peritoneal fat (cm3) 2243.32 46774.30 24433.28 22231.98
Subcutaneous fat (cm3) 59741.12 134556.08 95929.75 36293.45
IR (HOMA) 9.54 16.87 13.57 2.24
hs-CRP (ng/ml) 0.25 13.09 6.84 6.05
Adiponectin ((μg/ml)) 22.28 117.53 65.28 38.68
Leptin (ng/ml) 1.62 33.79 15.71 13.66
TNF-α (pg/ml) 6.50 19.42 13.66 5.75
Resistin (ng/ml) 2.16 49.82 25.28 20.36
BMI body mass index, IR insulin resistance, HOMA homeostasis model
assessment, TNF-α tumour necrotic factor -α.
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of body mass index. IP fat mass is the best predictor of
insulin resistance. In our study, we used CT for adipose
tissue evaluation and also for multiple compartments of
body measurement [12]. A strong relationship was noted
between IP fat and insulin resistance.A
C
B
Figure 2 The relation between insulin resistance index calculated by
intra-peritoneal fat and insulin resistance. B. No significant correlation betwee
between subcutaneous fat and insulin resistance.In clinical practice, waist circumference as central obesity
was used and correlated waist circumference with
metabolic syndrome. However, waist circumference is
composed of abdominal SC fat, and intra-abdominal
fat. Intra-abdominal adipose tissue (visceral fat) is further
separated to IP fat and RP fat, a distinction which has
been validated in human cadavers [13]. Previous work had
verified that most of the intra-abdominal adipose tissue
mass is IP (61–71%) and a much smaller element is RP
(29–33%) [13].Marin et al’s study has shown IP fat, rather
than RP or SC fat, more strongly correlated with systemic
metabolic variables (e.g., plasma insulin, blood glucose
levels, glucose disposal rate, and systolic blood pressure).
There is a higher turnover of lipids in visceral than in the
other fat depots, which is closely correlated to systemic
insulin resistance and glucose metabolism [14]. However
in the study of Abate et al., subcutaneous truncal fat plays
a major role in obesity-related insulin resistance in men,
whereas IP fat and RP fat have a lesser role [15]. In this
study only 39 healthy men were included. The discrepancy
may be due to different body fat distribution in different
gender, age and ethnicity. For example, multiple insulin
resistance risk factors occur in apparently healthy Asian
Indians with normal body mass index (BMI) [16-18].
Altered body composition with greater abdominal fat
is associated with insulin resistance, hyperinsulinemia,HOMA and body fat distribution. A. Highly correlation between
n retro-peritoneal fat and insulin resistance. C. No significant correlation
Table 2 Correlation between fat distribution and chronic inflammatory markers (correcting for age and sex)
Fat distribution Intra-peritoneal fat (cm3) Retro-peritoneal fat (cm3) Subcutaneous fat (cm3) Total body fat (cm3)
Markers
Hs-CRP (ng/ml) r = 0.29, p = 0.004 r = 0.20, p = 0.084 r = 0.13, p = 0.216 r = 0.29, p = 0.004
Adiponectin (μg/ml) r = −0.20, p = 0.046 r = −0.13, p = 0.222 r = 0.19, p = 0.335 r = −0.29, p = 0.005
leptin (ng/ml) r = 0.44, p < 0.001 r = 0.36, p = 0.005 r = 0.54, p < 0.001 r = 0.61, p < 0.001
TNF-α (pg/ml) r = 0.05, p = 0.666 r = −0.36, p = 0.171 r = 0.08, p = 0.886 r = −0.08, p = 0.403
resistin (ng/ml) r = 0.08, p = 0.427 r = 0.03, p = 0.740 r = 0.05, p = 0.654 r = 0.03, p = 0.806
HOMA r = 0.23, p < 0.001 r = 0.02, p = 0.729 r = 0.05, p = 0.270 r = 0.18, p = 0.075
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fat (BF%) were studied in Taiwan, Taiwanese subjects had
a relatively lower BMI but a higher BF% than Caucasians.
In general, the newly proposed Asia-Pacific BMI cut-
offs for overweight (> or =23 kg/m2) and obesity (>
or =25 kg/m2) may be acceptable to both male and
female Taiwanese subjects. The corresponding BF%
cutoffs for obesity would be 25% in male and 38% in
female Taiwanese subjects, respectively [19]. In our study,
we found that IP fat compartment was the only fat com-
partment that significantly correlated to HOMA IR. SC
fat, which is controversial in previous studies, is not an
independent factor of insulin resistance in our studies.
This allows us to specifically determine which compart-
ment of fat is of primary importance in the etiology of
insulin resistance in Taiwanese people.
Many recent studies revealed that chronic inflammation
participates in the development of metabolic syndrome
related coronary artery disease. These prospective studies
also showed an association between central obesity (by
waist circumference) and chronic inflammation [20-22].
The hs-CRP value can also be used as an independent
predictor of coronary heart disease. The American Heart
Association identified this marker as the best clinical de-
tector for cardiovascular disease [23]. Published data also
show that visceral adipose tissue is strongly associated
with circulating levels of CRP [5,24,25]. In our study, the
hs-CRP is highly related to IP fat and total body adipose
tissue but not RP and SC fat. Here, we further specified
that IP fat appears to be the strongest predictor for high
hs-CRP.
Leptin, TNF-α, resistin and adiponectin are adipose
tissue secretary proteins. Leptin, TNF-α, and resistin
correlating with body fat mass, has been reported to be
associated with insulin resistance and atherosclerosis
[26,27]. On the other hand, adiponectin has antidiabetic
and antiatherogenic properties [28]. Our previous work
has confirmed that during weight reduction programs
adiponectin plasma levels increase while leptin levels
decrease [29]. Leptin levels were thought correlated with
total and subcutaneous adipose tissue, but not with
visceral adipose tissue [16,30]. However, in one studyinvestigating South Asian in American, leptin is strongly
correlated with both SC fat and visceral fat [31]. In this
Taiwanese group, our data clearly show that plasma leptin
is associated with all part of adipose tissue, but still the
primary relationship is with subcutaneous fat. Therefore,
for Taiwanese or Asian, leptin may not be the best predictor
for metabolic syndrome, only for general obesity alone. As
for adiponectin, our study showed adiponectin level was
inversely related to IP fat, but not associated with the SC
and RP fat. This result is similar to two studies in different
ethnicity [32,33]. We separated intra-abdominal fat
(visceral fat) to intra-pertonium and retro-peritonium,
which revealed adiponectin more related to IP fat than
fat mass of other area and may be the negative predictor
for metabolic syndrome.
TNF-α is an adipokine involved in systemic inflamma-
tion and is a member of a group of cytokines that stimu-
late the acute phase reaction. However, obesity, especially
IP fat accumulation needs long-term changes. Although
previous study revealed that TNF-α increases leptin gene
expression and circulating leptin levels [34], some data
revealed no correlation found between TNF-α with any
fat distribution [5,35]. In Beasley et al’ study, this large
across racial study demonstrates visceral fat is only
positively associated with TNF-α except in black men but
not white men [36]. These different results may indicate
ethnicity is important in characteristic of fat compartment
again. Resistin, a cysteine-rich 12.5 kDa adipocytokine with
a controversial history regarding its role in the pathogenesis
of obesity-mediated insulin resistance and type 2 diabetes
mellitus in rodent models, is still controversial in the role of
glucose metabolism in human, is probably involved in the
regulation of inflammatory processes rather than in insulin
sensitivity [34,37]. No relationship between fat distribution
and resistin is also found in our study. In our results, the
amount of IP fat was significantly positive correlated with
hs-CRP and leptin but negative correlated with adiponectin.
IP fat may be inherently different from RP and SC fat, e.g.,
in cellular composition, tissue dynamics, adipokine release,
and hormonal responses. The “portal theory” also assumes
inflammatory factors released from IP fat into the portal
vein directly contributes to hepatic insulin resistance [38].
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http://www.dmsjournal.com/content/6/1/49In conclusion, the findings of this study confirm that IP
fat is a strong predictor of insulin resistance and metabolic
syndrome in Taiwanese. These observations reinforce the
importance of treatment strategies designed to reduce
IP part rather than RP part of visceral fat. Our results
also suggest a relationship between IP adiposity and the
chronic inflammation process. This holds irrespective of
age or other potential confounders, and was more prom-
inent than the relationship between total obesity. It may
be that, through the inflammation process and adipokines,
a disproportionate accumulation of IP fat is associated
with increased coronary risk.
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